INDIVA LTD - NDVAF STOCK NEWS

Indiva Limited (TSXV: NDVA) announced on March 14, 2023, that Health Canada has classified its Wild Cherry and Life Lemon THC Lozenges as "edibles" instead of "extracts." As a result, production of these products has been halted while the company consults with advisors for potential resolutions. The affected products contain THC in various dosages (100 mg, 250 mg, and 500 mg per package). The Company had previously believed it complied with regulatory classifications based on extensive research. Indiva is exploring alternative packaging formats for these products moving forward.

Indiva Limited (TSXV:NDVA, OTCQX:NDVAF), a Canadian cannabis producer, has finalized amendments to its unsecured convertible debentures totaling $2,740,000, which mature on December 31, 2024 with a 10% interest rate. To address outstanding debts, the Company proposed a Shares for Debt Transaction, issuing 131,246 Common Shares at $0.12 each. Furthermore, the Board approved granting 425,000 RSUs and 1,580,000 Options to directors and employees under its incentive plan, potentially increasing share issuance significantly.

Indiva Limited (TSXV:NDVA, OTCQX:NDVAF) reported Q3 2022 results showing net revenue of $8.1 million, up 5.5% year-over-year, despite a 0.4% sequential decline. Gross revenue rose to $8.8 million, marking a 5.9% year-over-year increase. The company remains the market leader in the edibles category, with a 29.7% market share. New product launches, including Pearls by Grön gummies and Indiva Life Double Stuffed Sandwich Cookies, contributed to growth. However, gross profit margins declined to 28.9% due to delays in automation equipment and higher production costs, leading to a comprehensive loss of $2.6 million.

Indiva Limited (TSXV:NDVA; OTCQX:NDVAF), a leading Canadian cannabis producer, is set to release its financial results for the quarter ending September 30, 2022, on November 22, 2022, before the market opens. A conference call will follow at 8:30 AM (EST) to discuss these results, with participation available via phone. Indiva produces a variety of award-winning cannabis products, including Bhang Chocolate and Wana Sour Gummies, showcasing its commitment to quality and innovation.

Indiva Limited (NDVA) announced its Q2 2022 financial results, reporting gross revenue of $8.9 million, an 8.3% decrease sequentially and a 9.9% year-over-year decline. Year-to-date gross revenue increased to a record $18.6 million, up 11% from 2021. Net revenue for Q2 was $8.1 million, also down 8.5% sequentially and 9.7% year-over-year. Despite declining sales, Indiva remains a market leader in edibles with a 31.6% market share. The launch of new products, including Pearls by Grön, is expected to drive future growth. Operating expenses decreased due to lower administrative costs, and gross margins improved to 33.1% of net revenue.

Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) will announce its financial results for the second quarter ended June 30, 2022, on August 16, 2022. The results will be disclosed pre-market. A conference call is scheduled for the same day at 8:30 a.m. (EST), where management will discuss the earnings and provide insights into the company's performance. Investors are encouraged to join via phone or listen to the recorded replay available until September 16, 2022. Indiva is a prominent Canadian cannabis producer known for its innovative edible products and premium cannabis offerings.

Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) announced a shares for debt agreement to settle approximately $172,075.98 in outstanding debt related to accrued interest on convertible debentures and trade payables. The agreement involves issuing 1,012,209 common shares at a deemed price of $0.17 per share. Related parties, including key executives, are among the creditors. The transaction aims to conserve cash for business development and is subject to approval from the TSX Venture Exchange.

Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) announced positive outcomes from its annual general meeting with the re-election of all seven directors and the appointment of Ernst & Young LLP as auditors. The company reported strong initial orders from the Ontario Cannabis Store for Grön Pearls gummies, with deliveries commencing in July 2022. Additionally, Indiva's SKU listings at OCS increased to a total of 60. However, net revenue guidance was lowered due to product delivery delays, but the company expects growth in the second half of 2022 driven by new product launches.

Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) announced the granting of 1,680,000 stock options to employees, executive officers, and directors, exercisable at $0.21 per share until June 3, 2027. This issuance is in line with the Company’s amended equity incentive plan, allowing for options up to 10% of the outstanding share capital. Following this granting, Indiva has a total of 14,131,052 stock options issued, representing approximately 9.7% of its total share capital, enhancing employee retention and alignment with shareholder interests.